Skip to main content

Icu Medical Inc

ICUI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000883984

In the last 90 days, Icu Medical Inc insiders filed 0 open-market purchases and 7 sales; 288 institutions reported holding it in 13F filings for Q2 2026, worth $3.82B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Icu Medical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
6 insiders, $6.63M in total
Insiders trading
6
Net value
−$6.63M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Icu Medical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Icu Medical Inc
NameTitleLast reported holdingLast filingFilings, past year
Sanzone Virginia RuthVP, General Counsel14,604Sep 3, 20265
Bonnell Brian MichaelChief Financial Officer56,062Sep 1, 20264
Woolson DanielVP, GM-Infusion Capital17,062Aug 13, 20265
Sousa BenChief Information Officer3,076Aug 12, 20263
Voigtlander Christian B.Chief Operating Officer37,377Aug 11, 20263
Finney Elisha WDirector4,871Aug 11, 20263
Hoffmeister David FDirector6,004May 13, 20261
Kennedy Kolleen TDirector4,539May 13, 20261
Abbey DonaldDirector6,004May 13, 20262
Greenberg David C.Director9,214May 13, 20261
Hernandez LaurieDirector4,862May 13, 20261
Jain VivekChairman and CEO126,833Mar 16, 20262
Lopez George ADirector877,343IndirectMar 14, 20240
Smiths Group PLCOther: Former 10% Owner1,670,000IndirectMar 1, 20240
Smiths Group International Holdings LtdOther: Former 10% Owner1,670,000Mar 1, 20240
McGrody Kevin JChief Accounting Officer4,846Mar 8, 20220
Swinney Robert SDirector20,816Sep 15, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 3, 2026 (view filing)6:29 PM ETSep 3Same daySanzone Virginia RuthVP, General CounselSSale−4.86K$168.69−$819.2K−25.0%14.6K after4 lots10b5-1
Sep 1, 2026 (view filing)5:21 PM ETSep 1Same dayBonnell Brian MichaelChief Financial OfficerSSale−6.38K$175.00−$1.12M−10.2%56.1K after10b5-1
Aug 31, 2026 (view filing)4:43 PM ETAug 31Same dayBonnell Brian MichaelChief Financial OfficerSSale−9.31K$172.79−$1.61M−13.0%62.4K after4 lots10b5-1
Aug 13, 2026 (view filing)6:56 PM ETAug 13Same dayWoolson DanielVP, GM-Infusion CapitalSSale−5.42K$181.33−$982.3K−24.1%17.1K after
Aug 12, 2026 (view filing)4:33 PM ETAug 12Same daySousa BenChief Information OfficerSSale−2.25K$178.32−$401.2K−42.2%3.08K after
Aug 11, 2026 (view filing)6:18 PM ETAug 11Same dayVoigtlander Christian B.Chief Operating OfficerSSale−8.93K$182.93−$1.63M−19.3%37.4K after
Aug 11, 2026 (view filing)5:59 PM ETAug 11Same dayFinney Elisha WDirectorSSale−378$182.48−$69.0K−7.2%4.87K after
May 22, 2026 (view filing)May 22Same dayWoolson DanielPresidentSSale−2.12K$132.21−$280.7K−8.6%22.5K after
May 15, 2026 (view filing)May 141 daySanzone Virginia RuthVP, General CounselSSale−2.45K$124.08−$303.6K−11.2%19.5K after
May 13, 2026 (view filing)May 121 dayGreenberg David C.DirectorSSale−2.42K$122.91−$297.9K−23.3%7.96K after
Nov 25, 2025 (view filing)Nov 25Same dayWoolson DanielVP, GM-Infusion CapitalSSale−2.90K$152.35−$441.4K−20.4%11.3K after
Nov 12, 2025 (view filing)Nov 111 daySanzone Virginia RuthVP, General CounselSSale−930$142.35−$132.4K−14.6%5.46K after
Nov 12, 2025 (view filing)Nov 111 dayFinney Elisha WDirectorSSale−1.28K$140.42−$180.4K−24.3%4.00K after
Aug 27, 2025 (view filing)Aug 27Same dayGreenberg David C.DirectorPPurchase+1.20K$126.41+$151.7K+17.8%7.96K after2 lots
Aug 14, 2025 (view filing)Aug 14Same dayJain VivekChairman and CEOPPurchase+21.9K$112.83+$2.47M+20.3%130.1K after2 lots
May 30, 2025 (view filing)May 30Same daySanzone Virginia RuthVP, General CounselSSale−700$133.62−$93.5K−9.9%6.39K after
May 28, 2025 (view filing)May 27-281 dayVoigtlander Christian B.Chief Operating OfficerSSale−9.93K$129.74−$1.29M−62.0%6.09K after2 lots
May 23, 2025 (view filing)May 22-231 dayVoigtlander Christian B.Chief Operating OfficerSSale−9.92K$130.02−$1.29M−66.9%4.90K after2 lots
May 21, 2025 (view filing)May 20-211 dayVoigtlander Christian B.Chief Operating OfficerSSale−9.79K$135.05−$1.32M−72.5%3.71K after2 lots
May 20, 2025 (view filing)May 191 dayFinney Elisha WDirectorSSale−600$138.92−$83.4K−15.6%3.25K after
May 19, 2025 (view filing)May 16-193 daysVoigtlander Christian B.Chief Operating OfficerSSale−11.1K$139.00−$1.54M−82.3%2.39K after2 lots
May 15, 2025 (view filing)May 15Same daySousa BenChief Information OfficerSSale−2.00K$137.36−$274.7K−80.7%479 after
May 15, 2025 (view filing)May 14-151 dayVoigtlander Christian B.Chief Operating OfficerSSale−11.1K$137.10−$1.52M−82.3%2.39K after2 lots
May 13, 2025 (view filing)May 13Same dayGreenberg David C.DirectorSSale−1.94K$143.66−$279.0K−22.3%6.76K after
Jan 2, 2025 (view filing)Jan 2Same dayJain VivekChairman and CEOSSale−1.37K$155.48−$213.5K−1.3%104.6K after10b5-1
Dec 6, 2024 (view filing)Dec 6Same dayWoolson DanielVP, GM-Infusion CapitalSSale−2.24K$156.25−$350.2K−17.1%10.9K after
Dec 2, 2024 (view filing)Dec 2Same dayJain VivekChairman and CEOSSale−12.0K$162.91−$1.95M−10.3%104.6K after3 lots10b5-1
Nov 27, 2024 (view filing)Nov 27Same dayVoigtlander Christian B.Chief Operating OfficerSSale−1.43K$158.00−$225.9K−100.0%0 after
Nov 27, 2024 (view filing)Nov 27Same dayGreenberg David C.DirectorSSale−972$158.11−$153.7K−16.2%5.04K after
Nov 26, 2024 (view filing)Nov 25-261 dayVoigtlander Christian B.Chief Operating OfficerSSale−9.68K$161.14−$1.56M−100.0%0 after3 lots
Nov 4, 2024 (view filing)Nov 13 daysJain VivekChairman and CEOSSale−12.0K$171.84−$2.06M−10.3%104.6K after4 lots10b5-1
Oct 1, 2024 (view filing)Oct 1Same dayJain VivekChairman and CEOSSale−12.0K$178.47−$2.14M−10.3%104.6K after4 lots10b5-1
Sep 3, 2024 (view filing)Sep 3Same dayJain VivekChairman and CEOSSale−12.0K$163.46−$1.96M−10.3%104.6K after3 lots10b5-1
Aug 30, 2024 (view filing)Aug 30Same dayWoolson DanielVP, GM-Infusion CapitalSSale−2.50K$163.22−$408.4K−16.0%13.1K after
Aug 16, 2024 (view filing)Aug 16Same dayJain VivekChairman and CEOSSale−12.0K$156.04−$1.87M−10.3%104.6K after10b5-1
Aug 8, 2024 (view filing)Aug 8Same daySanzone Virginia RuthVP, General CounselSSale−2.05K$144.11−$295.4K−31.4%4.48K after10b5-1
May 30, 2024 (view filing)May 30Same dayVoigtlander Christian B.Chief Operating OfficerSSale−12.5K$103.95−$1.30M−100.0%0 after2 lots
May 16, 2024 (view filing)May 16Same dayFinney Elisha WDirectorSSale−300$104.95−$31.5K−12.4%2.13K after
May 10, 2024 (view filing)May 10Same daySousa BenChief Information OfficerSSale−2.00K$105.55−$211.1K−60.3%1.32K after
Mar 15, 2024 (view filing)Mar 15Same dayWoolson DanielVP, GM-Infusion CapitalSSale−791$98.27−$77.7K−5.4%14.0K after
Mar 14, 2024 (view filing)Mar 14Same dayLopez George ADirectorSSale−7.98K$101.87−$812.7K−0.9%877.3K after
Mar 14, 2024 (view filing)Mar 122 daysLopez George ADirectorSSale−1.52K$101.51−$154.5K−0.2%885.3K afterAmended
Mar 11, 2024 (view filing)Mar 83 daysSanzone Virginia RuthVP, General CounselSSale−3.30K$104.57−$345.1K−40.9%4.77K after
Mar 11, 2024 (view filing)Mar 4-87 daysLateLopez George ADirectorSSale−41.4K$106.01−$4.39M−11.5%319.6K after3 lots
Mar 5, 2024 (view filing)Mar 41 dayVoigtlander Christian B.Chief Operating OfficerSSale−13.6K$107.19−$1.46M−100.0%0 after3 lots
Mar 1, 2024 (view filing)Feb 291 daySmiths Group International Holdings LtdOther: Former 10% OwnerSSale−830.0K$106.08−$88.0M−33.2%1.67M afterDuplicate filing
Mar 1, 2024 (view filing)Feb 291 daySmiths Group PLCOther: Former 10% OwnerSSale−830.0K$106.08−$88.0M−33.2%1.67M after
Dec 1, 2023 (view filing)Dec 1Same dayWoolson DanielVP, GM-Infusion CapitalSSale−1.73K$88.03−$152.2K−14.9%9.88K after
Sep 11, 2023 (view filing)Sep 83 daysVoigtlander Christian B.Chief Operating OfficerSSale−6.85K$129.04−$883.9K−33.5%13.6K after2 lots
Jul 14, 2023 (view filing)Jul 122 daysJain VivekChairman and CEOSSale−30.0K$180.02−$5.40M−55.9%23.7K after10b5-1